NCT07337057 DEntal implaNt Set: Development and Implementation of a Standardized Outcome Set in Implant Dentistry
| NCT ID | NCT07337057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Tooth Loss / Rehabilitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-06-24 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-06-24 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rationale Over the past decades, the placement of dental implants and prosthetic rehabilitation has revolutionised dentistry overwhelmingly. It is generally regarded as a safe and reliable method due to the high predictability and survival rates. Survival of suprastructure and implant, health status of the peri-implant tissues and radiographic peri-implant marginal bone loss are commonly used criteria to assess the implant treatment outcome. Although this way of treatment evaluation is important to develop and deliver safe dental implants, it does not provide sufficient information for the development of value-based healthcare. With this new approach of health outcome measurement, in which patient reported outcomes and clinical outcomes are combined, new definitions of success are created that transform dental implant health care by informed decision making, quality improvement and reducing costs. If dentists and oral surgeons make treatment decisions based on this comprehensive health outcome, patients are more likely to receive high quality care and payers only pay for services that achieve results. Therefore, the development of an implant dentistry specific question set, a Dental Implant Standard Set, capturing both the clinicians' and patients' perspective of implant-related health outcomes is of utmost clinical relevance. Objective(s) A combination of patient-reported outcomes and clinical health outcomes in a Dental Implant Standard Set enables clinicians to evaluate care delivery and to compare performance in a comprehensive and meaningful way. Therefore, the main aim for this project is to implement a workable Dental Implant Standard Set for the dental implant professional to monitor and improve clinicians and patients' perception of peri-implant health following dental implant treatment, and to monitor and improve the performance of dental implant practice as a whole. Study type This is a prospectively designed multicenter cohort study including 30 dental practices in the Netherlands and Spain Study population A total of 1000 consecutive patients will be included by the participating dental practices within 12 months. Questionnaires regarding the clinical outcomes are administered to the dentists providing the dental implant care. PROMs are administered to the participating patients. Generally, patients aged 18-70 years that have an indication for implant supported fixed single or multiple tooth replacement or implant-supported removable prosthesis are eligible to participate. Methods the questionnaires are administered to the participating dentist (for clinical outcomes) and patients (Patient Reported Outcome Measures (PROMs) in combination with the collection of clinical and case mix variables at 6 time points: before and at implant placement, at prosthesis placement and 10-12 months after implant placement. The PROMs is administered via a Questionnaire Manager (QM), that is developed by an external company. Within the QM also case mix and clinical data are registered Burden and risks No risks are involved throughout the study The concise questionnaires to the patients and participating dentist will be a limited burden to the standard dental implant care. Recruitment and consent Treating clinicians will recruit participants for this project. Clinicians will provide the patient with a brief overview of the study. Participants will receive a digital questionnaire via a link with an informed consent form and contact details (of the principal investigator) for remaining questions. Data is not open accessible and patient specific data will be anonymously stored.
Eligibility Criteria
Inclusion Criteria: * Age 18-70 years * Indication for implant-supported fixed single or multiple tooth replacement * Indication for implant-supported removable prosthesis * Immediate implant placement cases * Implant placement after implant failure Exclusion Criteria: * Inadequate oral hygiene * Physical inability * Pregnancy * History of radiotherapy in head and neck region * Language barriers * Patients requiring soft tissue grafts prior to dental implant placement * Patients requiring bone augmentation with harvesting autogenous bone from intraoral sites prior to dental implant placement
Contact & Investigator
Eppo B Wolvius, Prof. PhD. DMD. MD.
PRINCIPAL INVESTIGATOR
Erasmus Medical Center
Frequently Asked Questions
Who can join the NCT07337057 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Tooth Loss / Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07337057 currently recruiting?
Yes, NCT07337057 is actively recruiting participants. Contact the research team at m.chin@erasmusmc.nl for enrollment information.
Where is the NCT07337057 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT07337057 clinical trial?
NCT07337057 is sponsored by Erasmus Medical Center. The principal investigator is Eppo B Wolvius, Prof. PhD. DMD. MD. at Erasmus Medical Center. The trial plans to enroll 1,000 participants.